METHOD OF TREATMENT OF IMMUNE CHECKPOINT INHIBITOR-RELATED IMMUNE ADVERSE EFFECTS

摘要

A method for treatment and/or reduction of occurrence of immune checkpoint inhibitor related immune adverse effects in a subject in need thereof, includes administering thymosin alpha 1 to the subject. The immune checkpoint inhibitor related immune adverse effects can include colitis, diarrhea, rash, elevated alanine amino transferase (ALT), hypothyroidism, or hypophysitis.